Alimera Sciences IPO year
What is the IPO year of Alimera Sciences?
The IPO year of Alimera Sciences Inc. is 2010
What is the definition of IPO year?
Initial public offering is a type of public offering in which shares of a company usually are sold to institutional investors that in turn, sell to the general public, on a securities exchange, for the first time.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
IPO year of companies in the Health Care sector on NASDAQ compared to Alimera Sciences
What does Alimera Sciences do?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Companies with ipo year similar to Alimera Sciences
- Chigo has IPO year of 2009
- Jade Road Investments has IPO year of 2009
- Equity Metals has IPO year of 2009
- Kerr Mines has IPO year of 2009
- China e-Wallet Payment has IPO year of 2009
- SQS India BFSI has IPO year of 2009
- Alimera Sciences has IPO year of 2010
- Broken Hill Prospecting has IPO year of 2011
- Apollo Global Management Inc has IPO year of 2011
- Hipo Resources has IPO year of 2011
- Cogra 48 SA has IPO year of 2011
- New Mountain Finance Corp has IPO year of 2011
- Marfrig Global Foods SA has IPO year of 2011